5,6-Dihydropyrimidin-4(3H)one derivatives, and antiedema composi

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544253, 560125, C07D23990, C07D23991, A61K 31505

Patent

active

041138686

ABSTRACT:
An antiedema compound of the formula: ##STR1## in which R.sup.1 is methyl, ethyl, cyclohexyl, phenyl, m-tolyl, p-tolyl, p-tert-butylphenyl, m-trifluoromethylphenyl, m-fluorophenyl, p-fluorophenyl, m-chlorophenyl, p-chlorophenyl, m-bromophenyl, p-bromophenyl, o-hydroxyphenyl, p-methoxyphenyl, p-nitrophenyl, benzyl, p-chlorobenzyl, m,p-dimethoxybenzyl, and o-pyridyl;

REFERENCES:
patent: 3047462 (1962-07-01), Maillard et al.
patent: 3631042 (1971-12-01), Vincent et al.
patent: 3696102 (1972-10-01), Cronin
patent: 3945960 (1976-03-01), Salmond
patent: 3994894 (1976-11-01), Salmond
patent: 3996227 (1976-12-01), Salmond
Maillard et al., Chem. Abstracts, 69 36,006q (1968).
Armarego et al., Chem. Abstracts, 74 76,384b (1971).
Kato et al., Chemical Abstracts 75 151,753x (1971).
Brown, Fused Pyrimidines, Interscience Publishers, N.Y. (1967), pp. 87-93.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

5,6-Dihydropyrimidin-4(3H)one derivatives, and antiedema composi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5,6-Dihydropyrimidin-4(3H)one derivatives, and antiedema composi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5,6-Dihydropyrimidin-4(3H)one derivatives, and antiedema composi will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2384637

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.